Ceapro Inc
XTSX:CZO
Intrinsic Value
Ceapro, Inc. engages in the development and marketing of natural products for personal care, cosmetic, human, and animal health industries. [ Read More ]
The intrinsic value of one CZO stock under the Base Case scenario is 0.29 CAD. Compared to the current market price of 0.24 CAD, Ceapro Inc is Undervalued by 18%.
Valuation Backtest
Ceapro Inc
Run backtest to discover the historical profit from buying and selling CZO stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Ceapro Inc
Current Assets | 18m |
Cash & Short-Term Investments | 11.4m |
Receivables | 1.1m |
Other Current Assets | 5.6m |
Non-Current Assets | 15.9m |
PP&E | 15m |
Intangibles | 10.4k |
Other Non-Current Assets | 931.8k |
Current Liabilities | 1.6m |
Accounts Payable | 1.2m |
Other Current Liabilities | 391.2k |
Non-Current Liabilities | 2.3m |
Long-Term Debt | 2m |
Other Non-Current Liabilities | 390.1k |
Earnings Waterfall
Ceapro Inc
Revenue
|
11.3m
CAD
|
Cost of Revenue
|
-6.2m
CAD
|
Gross Profit
|
5.1m
CAD
|
Operating Expenses
|
-8.9m
CAD
|
Operating Income
|
-3.8m
CAD
|
Other Expenses
|
1.1m
CAD
|
Net Income
|
-2.7m
CAD
|
Free Cash Flow Analysis
Ceapro Inc
CZO Profitability Score
Profitability Due Diligence
Ceapro Inc's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
Score
Ceapro Inc's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
CZO Solvency Score
Solvency Due Diligence
Ceapro Inc's solvency score is 74/100. The higher the solvency score, the more solvent the company is.
Score
Ceapro Inc's solvency score is 74/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CZO Price Targets Summary
Ceapro Inc
According to Wall Street analysts, the average 1-year price target for CZO is 1.08 CAD .
Shareholder Return
CZO Price
Ceapro Inc
Average Annual Return | 17.18% |
Standard Deviation of Annual Returns | 46.05% |
Max Drawdown | -84% |
Market Capitalization | 18.8m CAD |
Shares Outstanding | 77 659 000 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Ceapro, Inc. engages in the development and marketing of natural products for personal care, cosmetic, human, and animal health industries. The company is headquartered in Edmonton, Alberta. The firm's primary business activities relate to the development and marketing of various health and wellness products and technology relating to plant extracts. The firm operates through two segments: the active ingredient product technology industry and the cosmeceutical industry. The firm is engaged in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. The company supports the use of its extracts in cosmeceutical, nutraceutical and therapeutic products for humans and animals. Its pipeline Oat Beta Glucan and Avenanthramides. The Company’s wholly owned subsidiaries include Ceapro Technology Inc., Ceapro Active Ingredients Inc., Ceapro BioEnergy Inc., Ceapro (P.E.I) Inc., Ceapro USA Inc., and JuventeDC Inc.
Contact
IPO
Employees
Officers
The intrinsic value of one CZO stock under the Base Case scenario is 0.29 CAD.
Compared to the current market price of 0.24 CAD, Ceapro Inc is Undervalued by 18%.